2003
DOI: 10.1016/s0025-7753(03)73959-1
|View full text |Cite
|
Sign up to set email alerts
|

Síndrome de secreción inadecuada de hormona antidiurética asociado a hepatocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Although SIADH has been described in the setting of central nervous system disorders, secondary to medications, and in some malignancies [mainly small cell lung cancer, head and neck cancer, olfactory neuroblastoma (esthesioneuroblastoma), and blood malignancies] [ 2 4 ], it is very rarely associated with primary hepatocellular carcinoma. There have only been 3 previous remotely reported cases of this association based on our comprehensive and extensive review of the literature [ 5 – 7 ]. We report a case of a Guatemalan man diagnosed with SAIDH in the setting of primary hepatocellular carcinoma.…”
Section: Introductionmentioning
confidence: 99%
“…Although SIADH has been described in the setting of central nervous system disorders, secondary to medications, and in some malignancies [mainly small cell lung cancer, head and neck cancer, olfactory neuroblastoma (esthesioneuroblastoma), and blood malignancies] [ 2 4 ], it is very rarely associated with primary hepatocellular carcinoma. There have only been 3 previous remotely reported cases of this association based on our comprehensive and extensive review of the literature [ 5 – 7 ]. We report a case of a Guatemalan man diagnosed with SAIDH in the setting of primary hepatocellular carcinoma.…”
Section: Introductionmentioning
confidence: 99%